CEFYBO   02669
CENTRO DE ESTUDIOS FARMACOLOGICOS Y BOTANICOS
Unidad Ejecutora - UE
artículos
Título:
Prevalence and Clinical Features of Epilepsy in Argentine. A Community-Based Study
Autor/es:
MARIO O. MELCON, SILVIA KOCHEN, RODOLFO H. VERGARA
Revista:
NEUROEPIDEMIOLOGY.
Editorial:
Karger
Referencias:
Año: 2007 vol. 28 p. 8 - 15
ISSN:
0251-5350
Resumen:
Objective: To ascertain the prevalence of epilepsy in Junín,
a town of 70,00080,000 inhabitants from the Province of
Buenos Aires, Argentina. Background: S S ome South American
communities have reported extremely high prevalences
of epilepsy. We investigated whether Junín would also have
a high prevalence. Design/Methods: Systematic sampling
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
communities have reported extremely high prevalences
of epilepsy. We investigated whether Junín would also have
a high prevalence. Design/Methods: Systematic sampling
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
a town of 70,00080,000 inhabitants from the Province of
Buenos Aires, Argentina. Background: S S ome South American
communities have reported extremely high prevalences
of epilepsy. We investigated whether Junín would also have
a high prevalence. Design/Methods: Systematic sampling
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was the neurological evaluation of the
250 persons who were screened positive for epilepsy. Diagnoses
were based on defined diagnostic criteria. Results: As
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
of January 1, 1991 (prevalence day), 106 persons had epilepsy,
including 64 (60%) with active epilepsy. Among these, 9
(14%) were epilepsy cases newly diagnosed by survey neurologists,
and 50 (78%) were on antiepileptic treatment at
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
the time of the survey. Regarding the same 64 persons, seizures
were generalized in 37 (58%) and partial in 24 (38%).
Lifetime prevalence of epilepsy was 6.2/1,000 (6.3/1,000, age
adjusted to the world standard population). Total point
prevalence for active epilepsy was 3.8/1,000 (4.0 for females
and 3.5 for males). In addition, prevalence peaked at the
ages of 4059 for females and 04 for males. Conclusions :
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
This is one of the first community-based studies of epilepsy
in Argentina, and the prevalence results provide new epidemiological
data contributing to our understanding of the
different prevalence rates found in Latin America.
Copyright © 2007 S. Karger AG, Basel
communities have reported extremely high prevalences
of epilepsy. We investigated whether Junín would also have
a high prevalence. Design/Methods: Systematic sampling
was used to select 5,839 households (sampling fraction =
25%). Participating households amounted to 5,648 (97%),
with 17,049 persons. A two-phase case-finding strategy was
used. Phase 1 was the screening of the 17,049 persons, which
was performed by trained but medically unsophisticated interviewers.
Phase 2 was